Results 91 to 100 of about 9,362 (180)

Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants. [PDF]

Int J Mol Sci
Mostaq MS, Amin MN, Raphael A, Asbury C, Gupta A, Gu X, Han X, Sekulic D, Michalak P, Kang L, Liu YY.   +10 more
europepmc   +1 more source

Elevated serum glucosylsphingosine level in children with obesity: relation to plasma atherogenesis. [PDF]

Int J Obes (Lond)
Salah NY, Abdel Hakam D, Abdullah FA, Hamza MS, Ramadan EA, Mahmoud R.   +5 more
europepmc   +1 more source

Glucosylceramide synthase (GCS) [PDF]

Science-Business eXchange, 2010
openaire   +1 more source

In Situ Differential Analysis of α- and β-Glycosidase Activities in Lysosomes After Internalization Using Glucosylcerebroside-Based Liposomes. [PDF]

Int J Mol Sci
Wei Y, Kanie O.
europepmc   +1 more source

Targeting Sphingolipids in Breast Cancer: From Tumor Biology to Therapeutic Strategies. [PDF]

Oncol Res
Kim MH, Huh B, Park JW, Park WJ.
europepmc   +1 more source

Glycolipid transfer protein modulates vesicular trafficking from the endoplasmic reticulum in HeLa cells. [PDF]

J Biol Chem
Nurmi H, Englund L, Henriksson A, Lönnfors M, Mattjus P.   +4 more
europepmc   +1 more source

Age at onset of Parkinson's disease modulates the sphingolipid-dopaminergic interplay in autonomic progression. [PDF]

NPJ Parkinsons Dis
Ye Z, Zhang S, Liu Z, Wang J, Li J, Yu X, Yuan X, Chen Z, Yuan Z, Yang Z, Huang S, Weng Y, Yang D.   +12 more
europepmc   +1 more source

Glucosylsphingosine (Lyso-Gb1): An Update on Its Use as a Biomarker in Gaucher Disease. [PDF]

Int J Mol Sci
Carubbi F, Linari S, Spada M.
europepmc   +1 more source

Central Roles of Glucosylceramide in Driving Cancer Pathogenesis. [PDF]

Int J Mol Sci
Zhao X, Pandey MK.
europepmc   +1 more source

Repurposing Gaucher disease therapy for Saposin C deficiency: Proof-of-concept with eliglustat.

Mol Genet Metab
Minea C, Deegan PB.
europepmc   +1 more source